Latest Technology News

Santana Minerals has released an updated Pre-Feasibility Study for its Bendigo-Ophir Gold Project, showcasing higher gold grades, reduced capital costs, and robust financial returns that position the project as a compelling new gold mine in New Zealand.

EMVision Medical Devices has activated five of six pivotal trial sites for its emu™ bedside brain scanner, advancing towards FDA clearance while launching a parallel innovation study in Australia.

Power Minerals Limited has launched a new options offer linked to a recent $1.3 million placement, alongside updates on key project acquisitions and divestments. The prospectus outlines significant risks and strategic directions as the company navigates growth and financial challenges.

Betashares Capital Ltd has announced the Distribution Reinvestment Plan (DRP) issue prices for over 70 of its ETFs following the June 2025 distribution period, with elections due by early July and unit issuance mid-month.

Pure Hydrogen Corporation has confirmed that the delivery and formal acceptance of its Taurus Hydrogen Fuel Cell Prime Mover to Barwon Water is material information likely to affect its share price, responding to ASX queries on disclosure timing and compliance.

Codeifai Limited (ASX – CDE) has agreed to acquire Antenna Transfer, an AI-driven quantum-secure platform, marking a strategic expansion into next-generation digital security. The deal positions Codeifai at the forefront of quantum-resilient infrastructure for high-security industries.

Golden Horse Minerals has acquired full ownership of the Sorrel Copper Project from NT Minerals for $3 million, gaining significant copper exposure in a Tier-1 jurisdiction. The acquisition replaces a prior earn-in option and positions Golden Horse for resource growth amid rising copper demand.

Echo IQ has initiated a pivotal clinical validation study with the Mayo Clinic Platform to test its EchoSolv HF software, marking the final step before its planned FDA submission in late 2025.

Lode Resources has reported impressive high-grade antimony and silver intercepts from its ongoing drilling program at the Montezuma Project in Tasmania, revealing new lodes and extending mineralisation.

Mesoblast has secured FDA agreement on key requirements for its Biologics License Application for Revascor, targeting ischemic heart failure patients with reduced ejection fraction. The company aims for accelerated approval by year-end 2025.

Objective Corporation has agreed to acquire Isovist, a leading e-planning software provider for local governments in Australia and New Zealand, enhancing its Planning and Building sector capabilities.

archTIS Limited has secured A$7.5 million through a discounted share placement to fund expansion in the U.S. defence sector, deepen strategic partnerships, and accelerate product innovation focused on secure data collaboration.